School of Physical and Occupational Therapy, McGill University, Montréal, Québec, Canada.
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR), Montréal, Québec, Canada.
J Eval Clin Pract. 2021 Aug;27(4):976-988. doi: 10.1111/jep.13539. Epub 2021 Feb 15.
RATIONALE, AIMS AND OBJECTIVES: The Withdrawal Assessment Tool (WAT-1) is one of the most widely used clinician-reported outcome measures to evaluate iatrogenic withdrawal symptoms (IWS) in critically ill children. However, the WAT-1's measurement properties have not been aggregated. Aggregating psychometric research on the WAT-1 will enhance appropriate use, and outline gaps for future empirical research. The aim of this systematic review is to critically appraise, compare, and summarize the measurement properties and evidence quality, and describe the interpretability and feasibility of the WAT-1 for identifying IWS symptoms in critically ill children.
A systematic search of Medline, Embase and CINAHL was conducted from inception to 15 April 2020. Study inclusion/exclusion, data extraction, and measurement property evidence and the modified GRADE quality scoring were applied according to the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines.
Six studies were included in the review. There was sufficient, high-quality evidence for reliability, structural validity, criterion validity, measurement error, construct validity, and feasibility. More information is required to support the WAT-1's content validity, responsiveness, internal consistency, cross-cultural validity, and interpretability according to COSMIN guidelines.
The results of this review indicate that the WAT-1 is a precise, easy to use measure of IWS in critically ill children despite some measurement property inconsistencies and gaps in the publication record. More information is required to support its content validity, responsiveness, internal consistency, cross-cultural validity, and interpretability.
背景、目的和目标:撤药评估工具(WAT-1)是评估危重症儿童医源性撤药症状(IWS)最常用的临床报告结局测量工具之一。然而,WAT-1 的测量特性尚未被综合。综合 WAT-1 的心理测量研究将增强其适当使用,并为未来的实证研究确定差距。本系统评价的目的是批判性地评估、比较和总结 WAT-1 的测量特性和证据质量,并描述其在识别危重症儿童 IWS 症状方面的可解释性和可行性。
从开始到 2020 年 4 月 15 日,对 Medline、Embase 和 CINAHL 进行了系统搜索。根据共识基础的健康测量仪器选择标准(COSMIN)指南,应用研究纳入/排除标准、数据提取以及测量特性证据和改良的 GRADE 质量评分。
综述共纳入 6 项研究。对于可靠性、结构有效性、标准有效性、测量误差、结构有效性和可行性,有充分的高质量证据。根据 COSMIN 指南,还需要更多信息来支持 WAT-1 的内容有效性、反应度、内部一致性、跨文化有效性和可解释性。
本综述结果表明,尽管在发表记录中存在一些测量特性不一致和差距,但 WAT-1 是一种精确、易于使用的危重症儿童 IWS 测量工具。需要更多信息来支持其内容有效性、反应度、内部一致性、跨文化有效性和可解释性。